Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd. is a registered legal entity registered in Bermuda, and its current status with Bermuda Monetary Authority / Registrar of Companies is active. The company was incorporated on 18 March 2019 and lists its registered address as Hamilton, Bermuda. 4 shareholders are on record for Altamira Therapeutics Ltd., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Bermuda Monetary Authority / Registrar of Companies and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Shareholders of Altamira Therapeutics Ltd.
Four shareholders are currently on record for Altamira Therapeutics Ltd., held on the register of members, filed under the Companies Act 1981. The largest of these is Armistice Capital, LLC, holding 85.6% — a majority holding — followed by Citadel Advisors Llc at 12.5%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Officers
4
Directors and officers of Altamira Therapeutics Ltd.
Four officers are currently on record for Altamira Therapeutics Ltd., filed with Bermuda Monetary Authority / Registrar of Companies. Thomas Meyer Ph.d. serves as Founder, President, Chairman, Ceo & Md; Marcel Gremaud Cpa serves as Chief Financial Officer; Samuel A. Wickline M.d. serves as Chief Scientific Adviser; Covadonga Paneda serves as Chief Operating Officer. Management authority at Altamira Therapeutics Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Altamira Therapeutics Ltd.?
Four shareholders are currently on record for Altamira Therapeutics Ltd., held on the register of members, filed under the Companies Act 1981. The largest of these is Armistice Capital, LLC, holding 85.6% — a majority holding — followed by Citadel Advisors Llc at 12.5%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Altamira Therapeutics Ltd.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Altamira Therapeutics Ltd. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Altamira Therapeutics Ltd. have on record?
4 shareholders are shown on record for Altamira Therapeutics Ltd..
Is Altamira Therapeutics Ltd. still an active company?
Altamira Therapeutics Ltd.'s status on Bermuda Monetary Authority / Registrar of Companies is listed as active.
When was Altamira Therapeutics Ltd. incorporated?
Altamira Therapeutics Ltd. was incorporated on 18 March 2019, according to Bermuda Monetary Authority / Registrar of Companies.
What is Altamira Therapeutics Ltd.'s registered address?
The registered address on file for Altamira Therapeutics Ltd. is Hamilton, Bermuda.
Who are the officers/directors of Altamira Therapeutics Ltd.?
Four officers are currently on record for Altamira Therapeutics Ltd., filed with Bermuda Monetary Authority / Registrar of Companies. Thomas Meyer Ph.d. serves as Founder, President, Chairman, Ceo & Md; Marcel Gremaud Cpa serves as Chief Financial Officer; Samuel A. Wickline M.d. serves as Chief Scientific Adviser; Covadonga Paneda serves as Chief Operating Officer. Management authority at Altamira Therapeutics Ltd. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to Altamira Therapeutics Ltd.'s ownership over time?
This profile reflects a point-in-time snapshot from Bermuda Monetary Authority / Registrar of Companies. Zavia's monitoring API can track changes to Altamira Therapeutics Ltd.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Altamira Therapeutics Ltd.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Bermuda, so records like Altamira Therapeutics Ltd.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Bermuda Monetary Authority / Registrar of Companies and was last synced on 22 September 2026.